The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells
Open accessAbstract
We have previously shown that multidrug-resistant cancer cells display elevated levels of glucosylceramide (Lavie, Y., Cao, H., Bursten, S. L., Giuliano, A. E., and Cabot, M. C. (1996) J. Biol. Chem. 271, 19530-19536). In this study we used the multidrug-resistant human breast cancer cell line MCF-7-Adriamycin-resistant (AdrR), which exhibits marked accumulation of glucosylceramide compared with the parental MCF-7 wild type (drug-sensitive) cell line, to define the relationship between glycolipids and multidrug resistance (MDR). Herein it is shown that clinically relevant concentrations of tamoxifen, verapamil, and cyclosporin A, all circumventors of MDR, markedly decrease glucosylceramide levels in MCF-7-AdrR cells (IC50 values, 1. 0, 0.8, and 2.3 microM, respectively). In intact cells, tamoxifen inhibited glycosphingolipid synthesis at the step of ceramide glycosylation. In cell-free assays for glucosylceramide synthase, tamoxifen (1:10 molar ratio with ceramide) inhibited glucosylceramide formation by nearly 50%. In cell cultures, inhibition of glucosylceramide synthesis by tamoxifen is correlated with its ability to sensitize MCF-7-AdrR cells to Adriamycin toxicity. Moreover, treatment of cells with 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, likewise sensitized MCF-7-AdrR cells to Adriamycin. It is concluded that high cellular levels of glucosylceramide are correlated with MDR, and that glycolipids are a target for the action of MDR-reversing agents such as tamoxifen. The data entertain the notion that drug resistance phenomena are aligned with cell capacity to metabolize ceramide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Functions of Sphingolipids and Sphingolipid Breakdown Products in Cellular Regulation
Hannun, Y. A., & Bell, R. M. (1989) · Science · doi:10.1126/science.2643164 · Cited by 1,251
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Yusa, K., & TSURUO, T. (1989) · PubMed · Cited by 365
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Self-citationCyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
Slater, L. M., Sweet, P., Stupecky, M., & Gupta, S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112450 · Cited by 316
Nilsson, O., & Svennerholm, L. T. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07950.x · Cited by 283
Cited by
Zheng, W., Kollmeyer, J., Symolon, H., Momin, A., Munter, E., Wang, E., Kelly, S., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 560
Self-citationEnzymes of Sphingolipid Metabolism: From Modular to Integrative Signaling
Hannun, Y. A., Luberto, C., & Argraves, K. M. (2001) · Biochemistry · doi:10.1021/bi002836k · Cited by 500
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Mechanisms of tamoxifen-induced apoptosis
Mandlekar, S., & Kong, A.-N. T. (2001) · Apoptosis · doi:10.1023/a:1012437607881 · Cited by 394
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Metadata
- Authors
- Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A. E., & Cabot, M. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 272
- Issue
- 3
- Pages
- 1682-1687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2090980124
- Cited by
- 284
- References
- 31
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells. https://app.cochat.ai/papers/10.1074/jbc.272.3.1682
- The paper
- Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A. E., & Cabot, M. C. (1997). Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.272.3.1682
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.